Loading KYMR chartsβ¦
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading KYMR comparable companiesβ¦
| KYMRKymera Therapeutics, Inc.(opens in a new tab) | $12.68B | $0.10B | +133.8% | 0.0% | β396.0% | 124.05Γ | β |
|---|---|---|---|---|---|---|---|
| IPSCCentury Therapeutics, Inc.(opens in a new tab) | $0.30B | $0.11B | +1556.5% | β | β | β | β |
| DNAGinkgo Bioworks Holdings, Inc.(opens in a new tab) | β | $0.11B | β46.8% | β | β259.9% | β | β |
| FDMT4D Molecular Therapeutics, Inc.(opens in a new tab) | $0.83B | $0.09B | +278712.1% | β | β214.2% | 9.07Γ | β |
| AUTLAutolus Therapeutics plc(opens in a new tab) | $0.40B | $0.12B | +292.2% | 15.7% | β210.8% | 3.43Γ | β |
| Medianpeers, excl. KYMR | $0.40B | $0.11B | +924.3% | 15.7% | β214.2% | 6.25Γ | β |